Annual D&A
$536.00 K
+$172.00 K+47.25%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual depreciation & amortization is currently $536.00 thousand, with the most recent change of +$172.00 thousand (+47.25%) on 31 December 2023. During the last 3 years, it has risen by +$523.00 thousand (+4023.08%). ACRV annual D&A is now at all-time high.ACRV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$251.00 K
+$23.00 K+10.09%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly depreciation & amortization is currently $251.00 thousand, with the most recent change of +$23.00 thousand (+10.09%) on 30 September 2024. Over the past year, it has increased by +$118.00 thousand (+88.72%). ACRV quarterly D&A is now at all-time high.ACRV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$852.00 K
+$118.00 K+16.08%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock TTM depreciation & amortization is currently $852.00 thousand, with the most recent change of +$118.00 thousand (+16.08%) on 30 September 2024. Over the past year, it has increased by +$340.00 thousand (+66.41%). ACRV TTM D&A is now at all-time high.ACRV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.3% | +88.7% | +66.4% |
| 3 y3 years | +4023.1% | - | - |
| 5 y5 years | - | - | - |
ACRV Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4023.1% | at high | +457.8% | at high | +1793.3% |
| 5 y | 5 years | at high | +4023.1% | at high | +457.8% | at high | +1793.3% |
| alltime | all time | at high | +4023.1% | at high | +457.8% | at high | +1793.3% |
Acrivon Therapeutics Common Stock Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $251.00 K(+10.1%) | $852.00 K(+16.1%) |
| June 2024 | - | $228.00 K(+1.8%) | $734.00 K(+15.6%) |
| Mar 2024 | - | $224.00 K(+50.3%) | $635.00 K(+18.5%) |
| Dec 2023 | $536.00 K | $149.00 K(+12.0%) | $536.00 K(+4.7%) |
| Sept 2023 | - | $133.00 K(+3.1%) | $512.00 K(+3.4%) |
| June 2023 | - | $129.00 K(+3.2%) | $495.00 K(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $125.00 K(0.0%) | $444.00 K(+22.0%) |
| Dec 2022 | $364.00 K(+883.8%) | $125.00 K(+7.8%) | $364.00 K(+52.3%) |
| Sept 2022 | - | $116.00 K(+48.7%) | $239.00 K(+94.3%) |
| June 2022 | - | $78.00 K(+73.3%) | $123.00 K(+173.3%) |
| Mar 2022 | - | $45.00 K | $45.00 K |
| Dec 2021 | $37.00 K(+184.6%) | - | - |
| Dec 2020 | $13.00 K | - | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual depreciation & amortization?
- What is the all time high annual D&A for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual D&A year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly D&A year-on-year change?
- What is Acrivon Therapeutics Common Stock TTM depreciation & amortization?
- What is the all time high TTM D&A for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock TTM D&A year-on-year change?
What is Acrivon Therapeutics Common Stock annual depreciation & amortization?
The current annual D&A of ACRV is $536.00 K
What is the all time high annual D&A for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual depreciation & amortization is $536.00 K
What is Acrivon Therapeutics Common Stock annual D&A year-on-year change?
Over the past year, ACRV annual depreciation & amortization has changed by +$172.00 K (+47.25%)
What is Acrivon Therapeutics Common Stock quarterly depreciation & amortization?
The current quarterly D&A of ACRV is $251.00 K
What is the all time high quarterly D&A for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly depreciation & amortization is $251.00 K
What is Acrivon Therapeutics Common Stock quarterly D&A year-on-year change?
Over the past year, ACRV quarterly depreciation & amortization has changed by +$118.00 K (+88.72%)
What is Acrivon Therapeutics Common Stock TTM depreciation & amortization?
The current TTM D&A of ACRV is $852.00 K
What is the all time high TTM D&A for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high TTM depreciation & amortization is $852.00 K
What is Acrivon Therapeutics Common Stock TTM D&A year-on-year change?
Over the past year, ACRV TTM depreciation & amortization has changed by +$340.00 K (+66.41%)